Mather Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-692
| Closed | -$155K | – | 1474 |
|
2025
Q1 | $155K | Sell |
692
-15
| -2% | -$3.36K | ﹤0.01% | 657 |
|
2024
Q4 | $162K | Buy |
707
+6
| +0.9% | +$1.37K | ﹤0.01% | 629 |
|
2024
Q3 | $171K | Buy |
701
+74
| +12% | +$18.1K | ﹤0.01% | 619 |
|
2024
Q2 | $124K | Buy |
627
+24
| +4% | +$4.75K | ﹤0.01% | 748 |
|
2024
Q1 | $104K | Buy |
+603
| New | +$104K | ﹤0.01% | 695 |
|
2023
Q3 | – | Sell |
-1,425
| Closed | -$311K | – | 609 |
|
2023
Q2 | $311K | Buy |
1,425
+328
| +30% | +$71.7K | 0.01% | 452 |
|
2023
Q1 | $240K | Sell |
1,097
-165
| -13% | -$36.1K | ﹤0.01% | 448 |
|
2022
Q4 | $263K | Sell |
1,262
-291
| -19% | -$60.6K | 0.01% | 409 |
|
2022
Q3 | $339K | Sell |
1,553
-65
| -4% | -$14.2K | 0.01% | 346 |
|
2022
Q2 | $339K | Buy |
+1,618
| New | +$339K | 0.01% | 288 |
|